About us

Vaxinano Company

Vaxinano is a biotechnology company specializing in the pre-clinical and clinical development of human and veterinary vaccines. Vaxinano was created in 2016, based on 30 years of research and clinical trials in vaccinology using technology patented by Pr. Didier Betbeder.

Our approach is based on a unique and innovative antigen delivery system using bio-compatible, adjuvant-free and safe-by-design nanoparticles.